Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097289 · ClinicalTrials.gov registry record · NA
In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution
A NA study, sponsored by Terumo BCT.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03097289 is a NA study that has completed, run by Terumo BCT. The registered enrollment target is 33 participants.
The verdict
NCT03097289, a NA study, has completed, sponsored by Terumo BCT.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the quality of platelets collected on the Trima Accel system after storage for 5 days in a Platelet Additive Solution (PAS), called InterSol.
Interventions
- DEVICE Trima Accel system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-07-26 |
| Est. Completion | 2017-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03097289
The ClinicalTrials.gov registry entry for NCT03097289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terumo BCT, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trima Accel system is the first listed.
NCT03097289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03097289 about?
NCT03097289 is a clinical study titled "In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution". The purpose of this study is to evaluate the quality of platelets collected on the Trima Accel system after storage for 5 days in a Platelet Additive Solution (PAS), called InterSol.
What is the current status of trial NCT03097289?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-07-26. Estimated completion is 2017-11-24.
What interventions are being tested in trial NCT03097289?
The interventions under investigation include: Trima Accel system (DEVICE).
Who is sponsoring clinical trial NCT03097289?
This trial is sponsored by Terumo BCT, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.